Julie Guérin

ORCID: 0000-0003-2237-4305
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • COVID-19 epidemiological studies
  • SARS-CoV-2 and COVID-19 Research
  • Chronic Disease Management Strategies
  • Cardiovascular Health and Risk Factors
  • SARS-CoV-2 detection and testing
  • COVID-19 Clinical Research Studies
  • Pharmaceutical Practices and Patient Outcomes
  • Obstructive Sleep Apnea Research
  • Infection Control and Ventilation
  • Cardiac Health and Mental Health
  • Social Sciences and Governance
  • Bacillus and Francisella bacterial research
  • Agriculture and Rural Development Research
  • Poxvirus research and outbreaks
  • Yersinia bacterium, plague, ectoparasites research
  • Healthcare Systems and Practices
  • Viral Infections and Outbreaks Research
  • Neurological and metabolic disorders
  • Stuttering Research and Treatment
  • Diet and metabolism studies
  • Cardiovascular Syncope and Autonomic Disorders
  • Education, sociology, and vocational training
  • Diabetes Management and Research
  • Medication Adherence and Compliance

University of Pennsylvania
2019-2024

University of Maryland Medical Center
2024

University of Maryland, Baltimore
2020-2024

University of Geneva
2021

University Hospital of Geneva
2021

University of Ottawa
2010

Abstract Understanding the risk of infection from household- and community-exposures transmissibility asymptomatic infections is critical to SARS-CoV-2 control. Limited previous evidence based primarily on virologic testing, which disproportionately misses mild infections. Serologic measures are more likely capture all previously infected individuals. We apply household transmission models data a cross-sectional, household-based population serosurvey 4,534 people ≥5 years 2,267 households...

10.1038/s41467-021-23733-5 article EN cc-by Nature Communications 2021-06-15

Abstract Background Serological assays detecting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are being widely deployed in studies and clinical practice. However, the duration effectiveness of protection conferred by immune response remains to be assessed population-based samples. To estimate incidence newly acquired SARS-CoV-2 infections seropositive individuals as compared seronegative controls, we conducted a retrospective longitudinal matched study....

10.1093/cid/ciab495 article EN other-oa Clinical Infectious Diseases 2021-05-25

Abstract Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, protect workers limit spread. Here, we present results from SEROCoV-WORK + study, a serosurvey of recruited after the first wave COVID-19 pandemic in Geneva, Switzerland. We tested (May 18—September 18, 2020) 16 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) positive. The...

10.1038/s41467-021-23796-4 article EN cc-by Nature Communications 2021-06-08

Abstract Aims Patients with heart failure (HF) experience various signs and symptoms have difficulties in perceiving them. Integrating insights from patients who engaged the process of symptom perception is crucial for enhancing our understanding theoretical concept perception. This study aimed to describe how HF perceive through processes monitoring, awareness, evaluation what influences process. Methods results Using a qualitative descriptive design, we conducted in-person semi-structured...

10.1093/eurjcn/zvad116 article EN European Journal of Cardiovascular Nursing 2024-01-03

A high prevalence of mpox in men who have sex with and people HIV, plus visually striking contagious lesions, raised concerns for stigma. 24 PCR-confirmed patients were surveyed over the course three months, utilizing an stigma scale adapted from HIV Stigma Scale assessment pain, analgesic efficacy, healthcare experiences. Participants cis-male (100%), male sexual partners (96%), mostly African-American (88%), living (79%). Patients answered 4-16 (mean 10) questions affirmatively,...

10.1371/journal.pone.0299587 article EN cc-by PLoS ONE 2024-05-21

10.1016/j.cardfail.2019.07.539 article EN Journal of Cardiac Failure 2019-08-01

Despite the high prevalence of depression in HF, little is known about how affects symptom perception processes monitoring, detection, and evaluation. If impairs perception, it may delay care-seeking. Aim: To explore influences HF perception. Methods: We enrolled a purposive sample patients with an unplanned hospitalization this convergent mixed-methods study. Semi-structured in-person interviews were used to monitored, detected, evaluated symptoms prior hospitalization. physical...

10.1161/circ.142.suppl_3.13361 article EN Circulation 2020-11-17

Perceiving symptoms is needed before one can respond to symptoms, but little known about the difficulties experienced by patients with heart failure (HF) as they engage in complex processes of symptom monitoring, awareness, and evaluation. Aim: To explore perception describe characteristics who consistently perceive HF symptoms. Methods: Using a convergent mixed methods design, we enrolled purposeful sample 40 adults an unplanned hospitalization for exacerbation. Quantitative data were...

10.1161/circ.146.suppl_1.9927 article EN Circulation 2022-11-08

Effective symptom perception may prevent unplanned hospitalizations. However, patients with heart failure (HF) often face challenges that interfere perception. Little is known about how perceive their HF symptoms. Aim: To describe symptoms through the processes of monitoring, awareness, and evaluation. Methods: Using a qualitative descriptive design, we conducted semi-structured in-person interviews purposeful sample adults experiencing an hospitalization for exacerbation. We elicited...

10.1161/circ.144.suppl_1.10111 article EN Circulation 2021-11-16
Coming Soon ...